Warren A. Kaplan, PhD, JD, MPH

Clinical Assistant Professor, Global Health
Warren Kaplan
(617) 414-1152wak@bu.edu
Crosstown Center
View full profile at BUMC

Biography

Intellectual property, trade and public health Access to medicines and devices Pharmaceutical policy Prevention and treatment of diabetes Pharmaceutical pricing and market dynamics

Education

  • Boston University, PhD
  • Boston University School of Public Health, MPH
  • Texas A & M University, MS
  • City University of New York--queens Coll, BA
  • Suffolk University, JD

Classes Taught

  • SPHGH885
  • SPHGH891
  • SPHGH943
  • SPHPH740
  • SPHPH740

Publications

  • Published on 5/16/2017

    Kaplan WA, Ashigbie PG, Brooks MI, Wirtz VJ. Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies. J Pharm Policy Pract. 2017; 10:17. PMID: 28523128.

    Read at: PubMed
  • Published on 10/12/2016

    Sharma A, Kaplan WA. Challenges constraining access to insulin in the private-sector market of Delhi, India. BMJ Glob Health. 2016 Nov; 1(3):e000112. PMID: 28588966.

    Read at: PubMed
  • Published on 10/10/2016

    Lee YH, Ang TF, Chiang TC, Kaplan WA. Growing concerns and controversies to Taiwan's National Health Insurance-what are the lessons from mainland China, South Korea and Singapore? Int J Health Plann Manage. 2016 Oct 10. PMID: 27723118.

    Read at: PubMed
  • Published on 10/4/2016

    Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries". Circulation. 2016 Oct 04; 134(14):e305-e306. PMID: 27698055.

    Read at: PubMed
  • Published on 7/19/2016

    Kaplan WA, Beall RF. The global intellectual property ecosystem for insulin and its public health implications: an observational study. J Pharm Policy Pract. 2017; 10:3. PMID: 27446593.

    Read at: PubMed
  • Published on 6/1/2016

    Mishra SR, Sharma A, Kaplan WA, Adhikari B, Neupane D. Liberating data to combat NCDs. Lancet Diabetes Endocrinol. 2016 Jun; 4(6):482-3. PMID: 27207276.

    Read at: PubMed
  • Published on 5/24/2016

    Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation. 2016 May 24; 133(21):2076-85. PMID: 27217433.

    Read at: PubMed
  • Published on 5/18/2016

    Mishra SR, Sharma A, Kaplan WA, Adhikari B, Neupane D. (2016). Lancet Diabetes & Endocrinology. 2016.

    Read at: Custom
  • Published on 3/14/2016

    Sharma A, Kaplan WA, Chokshi M, Zodpey SP. Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009-12. Health Policy Plan. 2016 Sep; 31(7):884-96. PMID: 26976803.

    Read at: PubMed
  • Published on 2/24/2016

    Beall RF, Nickerson JW, Kaplan WA, Attaran A. Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products? PLoS One. 2016; 11(2):e0148939. PMID: 26910128.

    Read at: PubMed

View 16 more publications:View full profile at BUMC

News & In the Media